Janus Henderson Group PLC Purchases 23,650 Shares of Revvity, Inc. (NYSE:RVTY)

Janus Henderson Group PLC boosted its position in shares of Revvity, Inc. (NYSE:RVTY - Free Report) by 0.4% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 6,358,952 shares of the company's stock after purchasing an additional 23,650 shares during the quarter. Janus Henderson Group PLC owned about 5.23% of Revvity worth $709,725,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Assetmark Inc. raised its holdings in Revvity by 3,700.0% during the 4th quarter. Assetmark Inc. now owns 266 shares of the company's stock worth $30,000 after purchasing an additional 259 shares during the last quarter. Optiver Holding B.V. bought a new stake in Revvity during the 4th quarter worth about $33,000. Quarry LP raised its holdings in Revvity by 45.7% during the 4th quarter. Quarry LP now owns 303 shares of the company's stock worth $34,000 after purchasing an additional 95 shares during the last quarter. Millstone Evans Group LLC bought a new stake in Revvity during the 4th quarter worth about $38,000. Finally, MassMutual Private Wealth & Trust FSB raised its holdings in Revvity by 55.9% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 385 shares of the company's stock worth $43,000 after purchasing an additional 138 shares during the last quarter. 86.65% of the stock is owned by institutional investors.

Analyst Ratings Changes

RVTY has been the subject of several recent research reports. Barclays dropped their price objective on Revvity from $140.00 to $110.00 and set an "overweight" rating for the company in a report on Thursday, April 10th. UBS Group raised Revvity from a "neutral" rating to a "buy" rating and dropped their price objective for the stock from $145.00 to $115.00 in a report on Thursday, May 1st. Robert W. Baird decreased their target price on Revvity from $127.00 to $125.00 and set an "outperform" rating for the company in a research report on Tuesday, April 29th. JPMorgan Chase & Co. decreased their target price on Revvity from $120.00 to $100.00 and set a "neutral" rating for the company in a research report on Tuesday, April 29th. Finally, Wells Fargo & Company decreased their target price on Revvity from $130.00 to $102.00 and set an "equal weight" rating for the company in a research report on Thursday, April 17th. Four investment analysts have rated the stock with a hold rating, ten have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $125.64.

Revvity Stock Down 5.7%

Shares of RVTY traded down $5.50 on Wednesday, hitting $91.21. The company's stock had a trading volume of 1,744,259 shares, compared to its average volume of 947,468. The company has a quick ratio of 3.03, a current ratio of 3.60 and a debt-to-equity ratio of 0.41. The firm's fifty day moving average price is $99.71 and its 200-day moving average price is $110.73. Revvity, Inc. has a fifty-two week low of $88.53 and a fifty-two week high of $129.50. The firm has a market capitalization of $10.75 billion, a price-to-earnings ratio of 41.27, a P/E/G ratio of 3.82 and a beta of 1.02.

Revvity (NYSE:RVTY - Get Free Report) last issued its quarterly earnings data on Monday, April 28th. The company reported $1.01 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.96 by $0.05. Revvity had a return on equity of 7.68% and a net margin of 9.81%. The business had revenue of $664.76 million during the quarter, compared to analyst estimates of $662.30 million. During the same period in the previous year, the firm earned $0.98 EPS. Revvity's quarterly revenue was up 2.3% compared to the same quarter last year. On average, equities research analysts expect that Revvity, Inc. will post 4.94 EPS for the current year.

Revvity Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 8th. Investors of record on Friday, July 18th will be given a $0.07 dividend. The ex-dividend date is Friday, July 18th. This represents a $0.28 annualized dividend and a dividend yield of 0.31%. Revvity's dividend payout ratio is presently 11.91%.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.